Market: Spectacular All Around

Published 10/16/2017, 10:20 PM

Good news is here, investing friends! Q3 earnings results are not only clear and present, but results are better than expected among most household name stocks ahead of the bell this morning. In a quarter rife with stresses from the nation’s capital, natural disasters both here and abroad, and other stock market headwinds, stronger-than-expected earnings are providing a good tonic for us this morning.

Goldman Sachs (NYSE:GS) tore the cover off the ball, figuratively speaking. The Wall Street investment giant easily surpassed top and bottom-line estimates: $5.02 per share beat the $4.31 expected, and revenues of $8.3 billion topped the $7.6 billion in the Zacks consensus estimate. This was also higher than the $8.2 billion recorded in the year-ago quarter. This marks the fourth quarter in the last five that Goldman Sachs has beaten earnings estimates, for a 4-quarter trailing average of 11.6%.

Morgan Stanley (NYSE:MS) also beat expectations for both earnings and revenues: the investment bank’s top line brought in $9.2 billion, versus the $9.0 billion expected, on earnings per share of 93 cents — easily outpacing the 81 cents anticipated. Investment banking revenues, in particular, grew 18.4% in the company’s Q3.

Household products giant Johnson & Johnson (NYSE:JNJ) beat earnings estimates by a solid dime to $1.90 per share, as top-line results also came in above expectations: $19.65 billion versus $19.28 billion in the Zacks consensus. Guidance for fiscal 2017 was also raised. Pharma sales in the quarter grew an impressive 15.4%.

For its fifth straight earnings beat (at least), United Healthcare (NYSE:UNH) also posted a positive surprise ahead of today’s opening bell: $2.66 per share bested the $2.57 expected. Revenues of $50.3 billion in the quarter rose 8.7% year over year on growth in medical enrollment.

On the other side of the street, Harley Davidson (NYSE:HOG) illustrated some of the difficulties in today’s market, just meeting the 40 cents per share expected in the Zacks consensus, down 40% from year-ago results. Sales of $962.1 million did top the $960.8 million expected, but these numbers are both down from the $1.1 billion reported in Q3 2016. Baby boomers buying fewer bikes looks to be the culprit here; in related news, Peter Fonda is 77 years old.

New Import/Export Numbers

September results for both import and export prices beat expectations this morning, up 0.7% last month from the 0.6% consensus, as well as the unrevised headline from the previous month. Exports performed even better, up 0.8% as opposed to the +0.5% expected. Imports year over year are in-line at +1.9%, while exports are +2.7% since this time last year. More grist for the interest rate hike mill. You know the Fed is paying attention to this.



Johnson & Johnson (JNJ): Free Stock Analysis Report

Morgan Stanley (MS): Free Stock Analysis Report

Goldman Sachs Group, Inc. (The) (GS): Free Stock Analysis Report

Harley-Davidson, Inc. (HOG): Free Stock Analysis Report

UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.